Moreover, Kuo and colleagues showed that PGG treatment decreased the MMP-9 activity in prostate cancer cells and inhibited bone metastasis by blocking the EGF-induced JNK1/2 and NF-κB signaling pathways [44]. The gene discussed is NFKB1; the disease is prostate cancer.